TrialThe Lancet. Oncology2021

Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.

Roberto Orecchia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.